HomeLifestyleRetailARGX, GTHX, MRSN: How Biotech Can Be A Defensive Play

ARGX, GTHX, MRSN: How Biotech Can Be A Defensive Play

This is a good time to look at biotech since it tends to hold up relatively well during bear markets and recessions, says Andrew Wang. He and David Nierengarten discuss the biotech sector. They talk about how Wedbush has outperform ratings for ARGX, GTHX, MRSN, TSVT, and SRRK. They also go over why the biotech sector could be a defensive play. Next, they mention investing strategies for biotech stocks. Tune in to find out more about the stock market today.

Trading 360

13 Jan 2023

SHARE

ON AIR
5:00 pm
Trading 360
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
ON AIR
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now